Search

everythinglearnresearchcommunity

for

Search:↓

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The document concludes that understanding hair loss and its psychological impact is crucial for physicians to provide effective counseling and treatment to patients.

The document concludes that while some hair and scalp disorders can be treated, hair loss from destroyed follicles is permanent, and damaged hair can only regrow naturally.

Synthetic hair implants can cause scalp cancer years later.

Female Pattern Hair Loss is linked to genetics, diet, stress, and certain health conditions.

Verilich serum effectively and safely improves hair loss treatment.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Nanotechnology therapies can help improve quality of life for those with hair loss.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

Diffuse hair loss significantly worsens quality of life for females, especially younger women and those with long-term hair loss.

Children with chronic kidney disease often have skin, hair, and nail problems.

Diffuse hair loss in women is often linked to anemia, thyroid issues, and conditions like polycystic ovarian disease.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

PRP hair treatment is generally safe but may cause minor pain, bleeding, redness, and scalp tightness, and isn't suitable for everyone.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

High-stress mothers had lower hair cortisol than low-stress mothers, and daughters' cortisol was linked to their stress response.

Frizzy hair is fragile and can lead to hair loss and damage if not properly cared for.

Proper planning for hair transplants is crucial for natural results, with careful patient selection and strategic graft placement being key factors.

Platelet-released growth factors can treat hair loss by activating hair follicle stem cells, blocking certain pathways, and controlling inflammation and fibrosis.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.